GlassScriptPhysician profile
Bryce Forrest Chapman
NPI 1447816822
$3,476.34
in general payments reported to CMS, 2019-2025
30 companies · $1,699 in 2025
The $1,699 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.48 · 2021: $29.29 · 2022: $35.09 · 2023: $335 · 2024: $1,363 · 2025: $1,699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,382 · Education: $15.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,381.95 |
| Education | $15.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $637.99 | 2023-2025 | Ubrelvy |
| Novo Nordisk INC | $405.63 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $355.04 | 2023-2025 | |
| Lilly USA, LLC | $330.54 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Amgen INC. | $231.66 | 2024-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $179.88 | 2023-2025 | Trelegy Ellipta, Shingrix |
| Medtronic, INC. | $170.77 | 2025 | Symplicity G3 |
| Otsuka America Pharmaceutical, INC. | $158.35 | 2023-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.26 | 2023-2025 | Jardiance, Synjardy, Tradjenta |
| Bayer Healthcare Pharmaceuticals INC. | $128.02 | 2023-2025 | |
| Exact Sciences Corporation | $117.00 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Dynavax Technologies Corporation | $101.79 | 2024-2025 | Heplisav-B |
| Phathom Pharmaceuticals, INC. | $75.84 | 2024-2025 | Voquezna |
| Idorsia Pharmaceuticals US INC | $62.54 | 2023-2024 | Quviviq |
| Astrazeneca Pharmaceuticals LP | $58.98 | 2024-2025 | Airsupra, Farxiga |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.13 | 2024-2025 | Caplyta |
| Axsome Therapeutics, INC. | $39.09 | 2024-2025 | Auvelity |
| Lundbeck LLC | $37.08 | 2025 | Rexulti |
| Regeneron Healthcare Solutions, INC. | $33.67 | 2024 | Evkeeza |
| Kowa Pharmaceuticals America, INC. | $21.08 | 2025 | Zoryve |
| Avion Pharmaceuticals | $17.71 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.38 | 2022 | |
| Dexcom, INC. | $16.07 | 2024 | Dexcom G6 Transmitter |
| Esperion Therapeutics, INC. | $15.55 | 2021 | |
| Opko Pharmaceuticals, LLC | $15.53 | 2024 | Rayaldee |
| Takeda Pharmaceuticals U.S.A., INC. | $14.48 | 2020 | |
| Astellas Pharma US INC | $14.37 | 2024 | Veozah |
| Globus Medical, INC. | $14.27 | 2025 | Senza |
| Abbott Laboratories | $13.90 | 2024 | Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $13.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryce Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.